Tianjin Medical University Cancer Institute And Hospital

This study tested two drugs, tislelizumab and lenvatinib, given before surgery to people with liver cancer that could be removed. The goal was to see if the drugs could shrink tumors and improve outcomes. 36 adults with early-stage liver cancer took part. The approach aims to mak…

This study tested a combination of two drugs (bevacizumab and a higher dose of icotinib) as a first treatment for people with advanced non-squamous lung cancer that has a specific genetic change (EGFR L858R). 35 patients took part. The goal was to see if the combo could keep the …

This study tested whether an AI-assisted contouring tool (iCurveE) helps doctors plan radiation therapy more accurately and quickly for people with lung, breast, or esophageal cancer. 500 participants had their CT scans contoured three ways: manually, by AI alone, and by AI with …

This study tested a risk scoring model that predicts whether stomach cancer has spread to nearby lymph nodes before surgery. Researchers collected data from 120 patients who had their stomach cancer removed to see how well the model works. The goal is to help doctors plan better …